189
9
2
12
4
Cat. No. | Product Name | ||
---|---|---|---|
L9830 | 抗帕金森病化合物库 | 857 compounds | |
857 种帕金森病相关的化合物集合,可用于高通量和高内涵筛选; | |||
L2630 | 神经元分化化合物库 | 672 compounds | |
672 种与神经元分化相关的化合物,可以用于神经系统疾病药物研发 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1880 |
P7C3
|
Others | Others |
P7C3 是一种 aminopropyl carbazole 类化合物,具有口服活性,可透过血脑屏障,具有神经保护作用。它可用于神经退行性疾病,如帕金森病的研究。 | |||
T3464 |
PHCCC
(-) PHCCC |
GluR | Neuroscience |
PHCCC ((-) PHCCC) 是 I 组代谢型谷氨酸受体拮抗剂和 mGluR4 的正变构调节剂。 它对 mGluR2 和 mGluR8 也有很强的拮抗作用,具有抗帕金森病作用。 | |||
T7729 |
PF-06454589
|
LRRK2 | Autophagy |
PF-06447475 是LRRK2激酶选择性抑制剂,可通透血脑屏障,能够抑制 WT LRRK (IC50:3 nM) 和 G2019S LRRK2 (IC50:11 nM) 。它可用于研究帕金森病 (PD) 。 | |||
T21667 |
FAUC-365
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
FAUC-365 是一种高度选择性的多巴胺D3受体拮抗剂,能够作用于 D3 受体(Ki:0.5 nM)、D4.4 受体(Ki:340 nM)、D2short 受体(Ki:2600 nM)和 D2Long 受体(Ki:3600 nM)。它可用于研究帕金森病、精神分裂症等疾病。 | |||
T1770 |
GNE-9605
|
LRRK2 | Autophagy |
GNE-9605 是一个高效,选择性和能脑渗透的LRRK2抑制剂,IC50为19 nM。 | |||
T2216 |
Entacapone
OR-611,恩他卡朋 |
Transferase | Metabolism |
Entacapone (OR-611) 是可逆的、具有口服活性的、外周作用的儿茶酚-O-甲基转移酶抑制剂。它对大鼠脑、红细胞和肝脏 COMT 有抑制作用。它对 COMT 的选择性优于其他儿茶酚胺代谢酶。它抑制 FTO 去甲基化活性,可用于研究代谢紊乱。它可用于研究帕金森病。 | |||
T4473 |
Ibiglustat
Venglustat,SAR402671,GZ402671 |
Transferase | Metabolism |
Ibiglustat (GZ402671) 是一种可透过血脑屏障的、具有口服活性的葡萄糖神经酰胺合成酶(GCS)抑制剂。它可用于戈谢病 3 型、法布瑞氏症、与 GBA 突变相关的帕金森病、GM2 神经节苷脂病和常染色体显性多囊肾病的研究。 | |||
T22026 |
AGK7
|
Others; Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair; Others |
AGK7 是 sirtuin 2 (SIRT2) 抑制剂。它在体外和帕金森病果蝇模型中均能抑制多巴胺能细胞的凋亡。在帕金森病细胞模型中,它改善了 α-突触核蛋白毒性和修饰的包涵体形态 | |||
T8737 |
GR 125743
|
5-HT Receptor | GPCR/G Protein; Neuroscience |
GR 125743 是选择性的5-HT1B/1D 受体拮抗剂,与野生型的人 h5-HT1B 和 5-HT1D 结合的pKi 分别为 8.85 和 8.31,可用于帕金森病和心血管疾病的研究。 | |||
T3053 |
CZC-25146
CHEMBL2397014 |
LRRK2 | Autophagy |
CZC-25146 (CHEMBL2397014) 是一种有效、特异性和代谢稳定的 LRRK2 抑制剂,对野生型 LRRK2 和 G2019S LRRK2 的 IC50 分别为 4.76 和 6.87 nM。 | |||
T9235 |
GW604714X
2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]- |
Mitochondrial Metabolism | Metabolism |
GW604714X (2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]-) 是一种高度特异性的线粒体丙酮酸载体抑制剂,Ki<0.1 nM。它是一种线粒体呼吸抑制剂。它也能抑制质膜单羧酸转运体的 L-乳酸转运,但浓度比 MPC 的大 4 个数量级。 | |||
T5139 |
CZC-25146 hydrochloride
|
LRRK2 | Autophagy |
CZC-25146 hydrochloride 是一种有效、特异性和代谢稳定的 LRRK2 抑制剂,对野生型 LRRK2 和 G2019S LRRK2 的 IC50 分别为 4.76 和 6.87 nM。 | |||
T1476 |
Pramipexole
SND 919,普拉克索 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
Pramipexole (SND 919) 是能够透过血脑屏障的 D2 型多巴胺受体的选择性激动剂,对 D2 型受体、D2、D3、D4亚型受体的Ki 分别为 2.2 nM、3.9 nM、0.5 nM、1.3 nM。它可用于研究帕金森综合症和腿多动综合征。 | |||
T2148 |
Carbidopa monohydrate
Carbidopa Hydrate,S(-)-Carbidopa,卡比多巴水合物 |
Decarboxylase; Aryl Hydrocarbon Receptor | Immunology/Inflammation; Metabolism; Others |
Carbidopa monohydrate (S(-)-Carbidopa) 是一种外周型脱羧酶抑制剂,可用于帕金森病的研究。它是一种选择性芳香烃受体 (AhR) 调节剂。它抑制胰腺癌细胞和肿瘤生长。 | |||
T6726 |
VU0361737
ML-128,VU 0361737 |
GluR | Neuroscience |
VU0361737 (ML-128) 是一种高效选择性的,中枢神经系统渗透性的代谢型谷氨酸受体 4(mGluR4)正变构调节剂,对人类和大鼠 mGluR4作用的EC50值分别为 240 和 110 nM。它具有神经保护作用,有用于帕金森氏病的研究潜力。 | |||
T4979 |
Procyclidine hydrochloride
(±)-Procyclidine hydrochlorid,丙环定盐酸盐 |
NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
Procyclidine hydrochloride ((±)-Procyclidine hydrochlorid) 是具有NMDA 拮抗剂特性的抗胆碱能试剂。 | |||
T3217 |
PF-CBP1 hydrochloride
PF-CBP1 HCl |
Epigenetic Reader Domain; Histone Acetyltransferase | Chromatin/Epigenetic |
PF-CBP1 hydrochloride (PF-CBP1 HCl) 是 CREB 结合蛋白溴结构域的一种高选择性抑制剂,抑制 CREBBP 和 EP300溴结构域的 IC50分别为 125 和 363 nM。它降低 LPS 诱导的巨噬细胞中炎症因子的表达,也可下调皮质神经元 RGS4 的表达,可用于癫痫和帕金森病等神经疾病的研究。 | |||
T0218 |
Biperiden
Bipariden,Akineton,KL 373,比哌立登,Biperidine |
AChR | Neuroscience |
Biperiden (Bipariden) 是中枢 M1胆碱受体阻断剂,有抗帕金森症活性。 | |||
T2592 |
Ropinirole hydrochloride
SKF 101468 hydrochloride,SKF-101468A,Ropinirole HCl,盐酸罗匹尼罗 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
Ropinirole hydrochloride (SKF-101468A) 是D3/D2受体激动剂,对 D2受体的Ki=29 nM。它对 hD2,hD3和 hD4受体的pEC50分别为 7.4、8.4 和 6.8。它对 D1受体没有亲和力。它对帕金森氏病具有潜在的研究价值。 | |||
T2226 |
Pergolide mesylate
甲磺酸培高利特,Pergolide mesylate salt,LY127809,Pergolide methanesulfonate |
Dopamine Receptor; 5-HT Receptor; Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Pergolide mesylate salt(LY127809) 是一种有效的,具有口服活性的多巴胺 D1和 D2受体激动剂,是一种 Ergoline 衍生物,可用于帕金森氏病和高泌乳素血症的研究。 | |||
T1336 |
Benztropine mesylate
Benzotropine mesylate,苯扎托品,Benzatropine mesylate,Benztropine methanesulfonate,甲磺酸苯扎托品 |
Dopamine Receptor; AChR; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Benztropine mesylate (Benztropine methanesulfonate) 是一种可口服的中枢性抗胆碱能剂,用于帕金森氏病的研究。它是抗组胺剂,抑制多巴胺的吸收。它也是人 D2多巴胺受体的变构拮抗剂,具有抗癌症干细胞的作用。 | |||
T0229 |
Rivastigmine
SDZ-ENA 713,卡巴拉汀,S-Rivastigmine,Exelon,利凡斯的明 |
AChE | Neuroscience |
Rivastigmine (Exelon) 是具有口服活性的、有效的、可透过血脑屏障的胆碱酯酶抑制剂,可抑制丁酰胆碱酯酶和乙酰胆碱酯酶,IC50分别为 0.037 μM 和 4.15 μM。它是一种拟副交感神经剂或胆碱能剂,用于研究轻度至中度阿尔茨海默氏型痴呆和帕金森氏病引起的痴呆。 | |||
T6951 |
Pramipexole dihydrochloride hydrate
Pramipexole 2HCl Monohydrate,普拉克索盐酸盐水合物,Mirapex,普拉克索 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
Pramipexole dihydrochloride hydrate (Mirapex) 是选择性的,具有血脑屏障 (BBB) 渗透性的 D2 型多巴胺受体激动剂,对 D2 型受体、D2、D3、D4亚型受体的 Ki 分别为 2.2 nM、3.9 nM、0.5 nM、1.3 nM,可用于研究帕金森综合症和腿多动综合征。 | |||
T1628 |
Rivastigmine tartrate
SDZ-ENA 713,ENA 713,酒石酸卡巴拉汀 |
AChR; AChE | Neuroscience |
Rivastigmine tartrate (SDZ-ENA 713) 是一种具有口服活性的、可透过血脑屏障的胆碱酯酶抑制剂,能够抑制丁酰胆碱酯酶和乙酰胆碱酯酶。它是一种拟副交感神经剂或胆碱能剂,用于研究轻度至中度阿尔茨海默氏型痴呆和帕金森氏病引起的痴呆。 | |||
T1406 |
Amantadine hydrochloride
盐酸金刚烷胺,1-adamantanamine HCl,1-Adamantanamine hydrochloride,Symmetrel,CI-719,Amantadine HCl,1-Adamantylamine hydrochloride |
Dopamine Receptor; Influenza Virus | GPCR/G Protein; Microbiology/Virology; Neuroscience |
Amantadine hydrochloride (CI-719) 是一种抗病毒药物,用于预防或对症治疗甲型流感和帕金森病。它阻断质子流通过 M2 离子通道,从而阻止病毒 RNA 释放到感染细胞的细胞质中。 | |||
TQ0289 |
LY450108
|
iGluR | Membrane transporter/Ion channel; Neuroscience |
LY450108 是有效的AMPA 受体增强剂,在抑郁和帕金森氏病中有研究的潜力。 | |||
T19922 |
L-m-Tyrosine
L(-)mTyrosine,3-羟基-L-苯基丙氨酸,L (-) m Tyrosine,LmTyrosine,3-Hydroxy-L-Phenylalanine,L-(-)-m-Tyrosine |
Others | Others |
L-m-Tyrosine (3-Hydroxy-L-Phenylalanine) 是一种非天然氨基酸。L-m-Tyrosine 在治疗帕金森病、关节炎和阿尔茨海默病方面显示出潜力。 | |||
T77333L |
(Iso)-BMT-124110 Formate
(R)-N-(8-((2-amino-2,4-dimethylpentyl)oxy)-5H-chromeno[3,4-c]pyridin-2-yl)acetamide Formate(1679370-98-9 Free base) |
AAK1 (AP2 associated kinase 1) | Neuroscience |
(Iso)-BMT-124110 Formate 对蛋白丝氨酸/苏氨酸激酶AAK 有抑制作用 ,可用于治疗 帕金森病、精神分裂症、神经性疼痛和阿尔茨海默病。 | |||
T71934 |
Atibeprone
|
MAO | Metabolism; Neuroscience |
Atibeprone 是 MAO-B 抑制剂,具有抗抑郁活性,可用于研究帕金森病。 | |||
T71707L |
Romergoline 2HCl
Romergoline 2HCl(107052-56-2 Free base),FCE 23884 2HCl |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
Romergoline 2HCl 是一种 D1 激动剂和 D2 拮抗剂,可用于研究帕金森病。 | |||
T4081 |
MPTP hydrochloride
MPTP-hydrochloride |
Apoptosis; Dopamine Receptor | Apoptosis; GPCR/G Protein; Neuroscience |
MPTP hydrochloride 是 MPP+ 的前体,是一种多巴胺神经毒素,具有血脑屏障渗透性。MPTP hydrochloride 对多巴胺能神经元有毒,可以导致帕金森症,被广泛应用于帕金森动物模型的构建。 | |||
T22595 |
B2
Linazolamide intermediate B impurity 2,CPNQ,5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline,奥司他韦杂质B(2-叠氮杂合物) |
Others; Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair; Others |
B2 (Linazolamide intermediate B impurity 2) 促进亨廷顿病和帕金森病细胞模型中的包涵体形成。 | |||
T24064 |
Fipamezole
JP-1730,BVF-025,JP 1730,JP1730 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Fipamezole 是一种有效的 α2肾上腺素能受体拮抗剂,可能用于研究帕金森病自主神经功能障碍。 | |||
T34616 |
Seridopidine
ACR-343,ACR 343,ACR343 |
Dopamine Receptor | GPCR/G Protein; Neuroscience |
Seridopidine (ACR343) 是一种多巴胺能活性调节剂,可作为精神分裂症、帕金森病和抽动秽语综合征的口服疗法。 | |||
T40018 |
SY2-062
4-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
Others | Others |
4-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 具有抗癌、治疗帕金森病的前药和抗炎药的潜力。 | |||
T62304 |
Minzasolmin
(R)-NPT200-11,UCB0599,DLX-313 |
Others | Others |
Minzasolmin(DLX-313) 是一种 α-突触核蛋白错误折叠抑制剂,可用于研究帕金森疾病。 | |||
T73397 |
ENT-C225
|
Trk receptor | Tyrosine Kinase/Adaptors |
ENT-C225 是一种高效的 TrkB 神经营养素受体(TrkBR)激活剂,具有神经保护活性,可用于研究阿尔茨海默病和帕金森病。 | |||
T26878 |
BN-82451 2HCl
BN-82451B 2HCl,BN 82451B 2HCl |
COX | Immunology/Inflammation; Neuroscience |
BN-82451 2HCl是 COX-1和COX-2 双重抑制剂,可用于研究亨廷顿舞蹈病和帕金森病。 | |||
T6946 |
Pimavanserin tartrate
ACP-103,ACP-103 tartrate,Nuplazid,Pimavanserin,匹莫范色林 |
5-HT Receptor | GPCR/G Protein; Neuroscience |
Pimavanserin tartrate (Nuplazid) 是一种有效的5-HT 2A 受体反向激动剂,pIC50和 pKi 值分别为8.73和9.3,用于治疗与帕金森病相关的精神病。 | |||
T13248 |
UK-240455
|
NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
UK-240455是一种有效的且具有选择性的 N-甲基 D-天冬氨酸 (NMDA) 甘氨酸受体拮抗剂,具有神经保护作用和改善帕金森病模型的运动的功能,是治疗帕金森病的潜在候选化合物。 | |||
T9970 |
mGluR3 modulator-1
1-ethyl-3-(morpholin-4-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile,1-乙基-3-(1,4-氧杂氮杂环己-4-基)-5,6,7,8-四氢异喹啉-4-甲腈 |
GluR | Neuroscience |
mGluR3 modulator-1 (1-ethyl-3-(morpholin-4-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile) 是 mGluR3 的正变构调节剂,可用于治疗帕金森病的研究。 | |||
T3278 |
Piribedil
EU-4200,Trivastan,ET-495,Trivastal |
Dopamine Receptor; Histone Methyltransferase; Adrenergic Receptor | Chromatin/Epigenetic; GPCR/G Protein; Neuroscience |
Piribedil (Trivastan) 是多巴胺 D2受体激动剂,对 hα1A-肾上腺素受体也显示出拮抗作用。 | |||
T125036 |
Bocconoline
|
||
Bocconoline 是一种在 Bocconia cordata WILLD中发现的生物碱, 具有潜在的抗癌活性,可用于研究帕金森病 (PD) 。 | |||
TQ0220 |
KR-33493
KR-33494,KM-819 |
Fas/FasL | Apoptosis |
KR-33493 是一种 FAS 相关因子 1 (FAF1) 抑制剂,可用于帕金森病研究。 | |||
T31773 |
Fenlean
FLZ |
Beta Amyloid; Src | Angiogenesis; Neuroscience; Tyrosine Kinase/Adaptors |
Fenlean (FLZ) 是酪氨酸激酶 Src 抑制剂,是来自Annona glabra的鳞甲酰胺的合成环状衍生物,具有细胞保护活性,在帕金森病慢性 MPTP/丙磺舒类小鼠模型中保护酪氨酸羟化酶功能。Fenlean 可以抑制线粒体中Aβ的产生,可用于研究年龄相关性黄斑变性和帕金森。 | |||
T24797 |
SK609 HCl
SK-609 hydrochloride,SK 609 HCl,SK609 hydrochloride,SK 609 hydrochloride,SK-609 HCl |
Dopamine Receptor; Norepinephrine | GPCR/G Protein; Neuroscience |
SK609 HCl (SK609 hydrochloride) 是一种多巴胺 D3 受体 (D3R) 选择性激动剂,抑制去甲肾上腺素转运蛋白,可用于研究帕金森病和认知障碍。 | |||
T28367L1 |
BDBM50597431
|
NMDAR | Neuroscience |
BDBM50597431 是一种 NMDA 受体调节剂,可能具有可用于研究阿尔滋海默症和帕金森综合征。 | |||
T81633 |
Nurr1 agonist 7
|
Others | Others |
Nurr1 agonist 7 是 Nurr1 的激动剂(EC50:0.12 μM),可用于研究帕金森等神经系统疾病。 | |||
T31592 |
E6801
E 6801,E-6801 |
5-HT Receptor | GPCR/G Protein; Neuroscience |
E6801是一种新型选择性5-HT6受体激动剂,具有广泛的生物活性。E6801可用于研究痴呆、帕金森病、抑郁症、肥胖症癫痫,焦虑等多种疾病。 | |||
T9759 |
MAO-B-IN-5
|
Others | Others |
MAO-B-IN-5 是一种有效的、选择性和具有口服活性的MAO-B 抑制剂,IC50值为 0.204 μM。MAO-B-IN-5 在帕金森病 (PD) 中具有研究潜力。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6795 |
Carbidopa
卡比多巴,(S)-(-)-Carbidopa,Lodosyn |
Decarboxylase; Aryl Hydrocarbon Receptor | Immunology/Inflammation; Metabolism; Others |
Carbidopa (Lodosyn) 是一种选择性芳香烃受体(AhR)调节剂,是外周型脱羧酶抑制剂,抑制胰腺癌细胞和肿瘤生长,可用于帕金森病的研究。 | |||
T0437 |
Inosine
INO 495,NSC 20262,肌苷 |
ROS; Endogenous Metabolite; Adenosine Receptor | GPCR/G Protein; Immunology/Inflammation; Metabolism; Neuroscience |
Inosine (NSC-20262) 是由腺苷分解代谢产生的一种内源性嘌呤核苷,是腺苷受体A1R 和A2AR 的激动剂,具有抗炎免疫调节,抗伤害和神经保护作用。 | |||
T7060 |
Amantadine
1-Aminoadamantane,1-金刚烷胺,金刚烷胺,1-Adamantanamine,1-Adamantylamine |
Others | Others |
Amantadine (1-Aminoadamantane) 是抗病毒药物,也是是 NMDA 型谷氨酸受体的弱拮抗剂,能促进高多巴胺的释放,并阻断多巴胺的再摄取。 | |||
T5S0754 |
Isoquercetin
3-Glucosylquercetin,Hirsutrin,Isoquercitrin,异槲皮苷,Quercetin 3-o-glucopyranoside,槲皮素-3-葡萄糖苷 |
NF-κB; Wnt/beta-catenin; NO Synthase | Cytoskeletal Signaling; Immunology/Inflammation; NF-κB; Stem Cells |
Isoquercetin (3-Glucosylquercetin) 是天然存在的多酚,具有抗氧化,抗增殖和抗炎特性。它通过调节核因子-κB 转录调节系统调节一氧化氮合酶 2 的表达。它通过 Nrf2/ARE 抗氧化剂信号传导途径减轻乙醇诱导的肝毒性,氧化应激和炎症反应。它具有高生物利用度和低毒性,是预防糖尿病妊娠出生缺陷的有希望的候选药物。 | |||
T0848 |
L-DOPA
左旋多巴,Levodopa,3,4-Dihydroxyphenylalanine |
Dopamine Receptor; Endogenous Metabolite | GPCR/G Protein; Metabolism; Neuroscience |
L-DOPA (Levodopa) 是的神经递质多巴胺的代谢前体,具有口服活性。Levodopa 能够透过血脑屏障,并在大脑中转化为多巴胺。Levodopa 具有抗痛觉过敏作用。Levodopa 还具有帕金森氏病的研究潜力。 | |||
T4S2126 |
Ginkgetin
银杏双黄酮,银杏素 |
Apoptosis; Wnt/beta-catenin; COX; STAT; Autophagy | Apoptosis; Autophagy; Cytoskeletal Signaling; Immunology/Inflammation; JAK/STAT signaling; Neuroscience; Stem Cells |
Ginkgetin 是从银杏叶中分离得到的一种双黄酮,具有抗肿瘤、抗炎、神经保护、抗真菌的作用。它也是 Wnt 信号抑制剂,IC50值为 5.92 μM。 | |||
TN5171 |
Tricetin
|
Apoptosis; Others; Nrf2 | Apoptosis; Immunology/Inflammation; Others |
Tricetin 是一种从石榴中分离出的类黄酮。Tricetin 是 Keap1-Nrf2 蛋白相互作用(PPI)的强效竞争性抑制剂,通过激活 Nrf2/HO-1 信号通路和阻止线粒体依赖性细胞凋亡通路,保护帕金森病患免受 6-OHDA 诱导的神经毒性的影响。Tricetin 通过 Akt/GSK-1β途径抑制鼻咽癌的迁移和指示性蛋白酶早老素-1(PS-1)表达。Tricetin 抑制由Egr-1介导的氧化LDL 诱导的内皮炎症,保护大鼠软骨细胞免受IL-1β诱导的炎症和细胞凋亡。 | |||
T4954L |
Smilagenin
PYM50028,Cogane,AI3-44895,PYM 50028 |
||
Smilagenin is an orally active inducer of nonpeptide neurotrophic factor. It also prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons, and by MPTP in a mouse model of Parkinson's disease. | |||
T15255 |
Etilevodopa
Levodopa ethyl ester,L-DOPA ethyl ester |
Others | Others |
Etilevodopa is an ethyl-ester prodrug of Levodopa which is used for the treatment of Parkinson's disease (PD). It is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Levodopa is the direct precursor of dop |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00135 |
BDNF Protein, Human/Murine/Rat, Recombinant
BDNF,Abrineurin,Brain-Derived Neurotrophic Factor |
Human,Mouse,Rat | E. coli |
Brain-Derived Neurotrophic Factor (BDNF) is a member of the neurotrophin family. Along with other structurally related neurotrophic factors NGF, NT-3 and NT-4, BDNF binds with high affinity to the TrkB kinase receptor. It also binds with the LNGFR (for low-affinity nerve growth factor receptor, also known as p75). BDNF promotes the survival, growth and differentiation of neurons. It serves as a major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. ... | |||
TMPY-01355 |
Transglutaminase 2/TGM2 Protein, Human, Recombinant (His)
G-α-h,HEL-S-45,TGC,transglutaminas |
Human | Baculovirus Insect Cells |
Protein-glutamine gamma-glutamyltransferase 2, also known as Tissue transglutaminase, Transglutaminase C, Transglutaminase-2, and TGM2, is a member of the transglutaminase superfamily. TGM2 plays a role in cell growth and survival through the anti-apoptosis signaling pathway. It is a calcium-dependent acyltransferase that also undergoes a GTP-binding/GTPase cycle even though it lacks any obvious sequence similarity with canonical GTP-binding (G) proteins. TGM2 is a multi-functional protein which... | |||
TMPK-01063 |
LRP-10 Protein, Mouse, Recombinant (His)
Lrp10,LRP-10,Lrp9 |
Mouse | HEK293 Cells |
LDL receptor-related protein (LRP) 10 was recently identified as a Parkinson's disease gene through genome-wide linkage and sequencing analysis, but its role in Parkinson's disease in various populations is still unclear. | |||
TMPY-02043 |
PARK7/DJ-1 Protein, Human, Recombinant (His)
DJ1,HEL-S-67p,DJ-1,parkinson prot... |
Human | E. coli |
Parkinson's disease locus DJ-1 (PARK7) is a differentially expressed transcript. DJ-1 plays a physiologic role in protection of erythroid cells from oxidant damage, a function unmasked in the context of oxidative stress. PARK7 belongs to the peptidase C56 family of proteins. It acts as a positive regulator of androgen receptor-dependent transcription. It may also function as a redox-sensitive chaperone, as a sensor for oxidative stress, and it apparently protects neurons against oxidative stress... | |||
TMPY-05099 |
GBA/glucocerebrosidase Protein, Human, Recombinant (His)
glucosidase, β, acid,GLUC,GCB,GBA1,gluco |
Human | HEK293 Cells |
Mutations in the GBA gene, encoding the lysosomal hydrolase glucocerebrosidase (GCase), are the most common known genetic risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB). ASAH1 (acid ceramidase 1) and GBA2 (glucocerebrosidase 2) enzymes that mediate glucosylsphingosine production and metabolism are attractive therapeutic targets for treating mutant GBA-associated PD. | |||
TMPJ-01022 |
SUMO3 Protein, Human, Recombinant (HEK293, His)
SMT3 homolog 1,Smt3A,Small ubiqui... |
Human | HEK293 Cells |
Small ubiquitin-like modifier (SUMO), also known as SUMO homologue and SMT3, is a member of the superfamily of ubiquitin-like polypeptides that become covalently attached to various intracellular target proteins as a way to alter their function, location, and/or half-life. Small ubiquitin-like modifiers include SUMO1, SUMO2, SUMO3, and SUMO4. Except for SUMO4, all other SUMOs are ubiquitously expressed, including in the brain. In human, SUMO2 and SUMO3 are two highly homologous proteins, collect... | |||
TMPY-03227 |
CISD1 Protein, Human, Recombinant (His)
ZCD1,CDGSH iron sulfur domain 1,C10orf70,m... |
Human | E. coli |
Mitochondrial dysfunction is thought to play a significant role in neurodegeneration observed in Parkinson's disease (PD), the loss of mitoNEET (CISD1), an iron-sulfur containing protein that regulates mitochondrial bioenergetics, results in mitochondrial dysfunction and loss of striatal dopamine and tyrosine hydroxylase. CDGSH iron sulfur domain 1 (CISD1, also termed mitoNEET), an iron-containing outer mitochondrial membrane protein, negatively regulates ferroptotic cancer cell death. At the ce... | |||
TMPY-00554 |
CHRNB3 Protein, Human, Recombinant (His)
cholinergic receptor, nicotinic, beta 3 (neuronal),cholinerg... |
Human | HEK293 Cells |
Cholinergic nicotinic receptor (CHRN) gene family has been known to mediate the highly additive effects of nicotine in the body, and implicated nicotine dependence (ND) and related phenotypes. Cigarette smoking is protective in Parkinson's disease (PD), possibly because of nicotine action on brain nicotinic-acetylcholine receptors. The beta3 nicotinic-acetylcholine receptor subunit (encoded by CHRNB3) is depleted in the striatum of PD patients and associated with nicotine dependence. CHRNB3 Prot... | |||
TMPY-04195 |
CHRNB3 Protein, Human, Recombinant (hFc)
cholinergic receptor, nicotinic, β 3 (neuronal),cholinergic ... |
Human | HEK293 Cells |
Cholinergic nicotinic receptor (CHRN) gene family has been known to mediate the highly additive effects of nicotine in the body, and implicated nicotine dependence (ND) and related phenotypes. Cigarette smoking is protective in Parkinson's disease (PD), possibly because of nicotine action on brain nicotinic-acetylcholine receptors. The beta3 nicotinic-acetylcholine receptor subunit (encoded by CHRNB3) is depleted in the striatum of PD patients and associated with nicotine dependence. CHRNB3 Prot... | |||
TMPY-03653 |
CTRL Protein, Human, Recombinant (His)
CTRL1,chymotrypsin-like |
Human | HEK293 Cells |
CTRL-1, also known as chymotrypsin-like protease, belongs to thepeptidase S1 family. CTRL-1 contains 1peptidase S1 domain. Its expression is increased in preeclampsia (PE). Placental-derived chymotrypsin-like protease is responsible for inducing endothelial inflammatory phenotypic changes possibly by upregulation of cell adhesion molecule expressions, activation of cellular protease, and induction of extracellular regulated kinase phosphorylation. Activated microglia have been observed in variou... | |||
TMPJ-00684 |
SNCA Protein, Mouse, Recombinant (His)
Snca,Non-A β component of AD amyloid,Non-A4 compone... |
Mouse | E. coli |
Alpha-synuclein (Snca) belongs to a family of proteins including a-, b-, and g-synucleins. Alpha-synuclein has been found to be implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson's disease (PD) and Alzheimer's disease. Manyneurodegenerative diseases has shown that alpha-synuclein accumulates in dystrophic neurites and in Lewy bodies. The function of alpha-synuclein is closely correlated with its three-dimensional structure, especially for proteins important... | |||
TMPY-02759 |
Kallikrein 6/KLK6 Protein, Human, Recombinant (His)
kallikrein-related peptidase 6,PRSS |
Human | HEK293 Cells |
KLK6 (kallikrein-related peptidase 6), also known as Klk7, belongs to the peptidase S1 family, Kallikrein subfamily. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK6 is a serine protease that exhibits a preference for Arg over Lys in the substrate P1 position and for Ser or Pro in the P2 position. Klk7 sh... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36903 |
Rasagiline-13C3 (mesylate)
Rasagiline-13C3 (mesylate) |
||
Rasagiline-13C3is intended for use as an internal standard for the quantification of rasagiline by GC- or LC-MS. Rasagiline is an inhibitor of monoamine oxidase B (MAO-B; IC50= 4.43 nM for the rat brain enzyme).1It is selective for MAO-B over MAO-A (IC50= 412 nM for the rat brain enzyme). It inhibits serum and NGF withdrawal-induced apoptosis of PC12 cells when used at concentrations ranging from 0.01 to 100 μM.2Rasagiline inhibits rat brain MAO-Bin vivo(ED50= 0.1 mg/kg).1It reduces cerebral ede... | |||
T10118 |
3-O-Methyltolcapone D7
Ro 40-7591 D7 |
Transferase | Metabolism |
3-O-Methyltolcapone D7 (Ro 40-7591 D7) is a deuterium labeled 3-O-Methyltolcapone. 3-O-Methyltolcapone (Ro 40-7591) is a metabolite of Tolcapone which is a potent COMT inhibitor. Tolcapone crosses the blood-brain barrier and can be used for treatment of P | |||
TMIJ-0312 |
L-Dopa-2,5,6-d3
|
||
L-Dopa-2,5,6-d3 是 L-Dopa 的氘代化合物。L-Dopa 的 CAS 号为 59-92-7。Levodopa 是的神经递质多巴胺的代谢前体,具有口服活性。Levodopa 能够透过血脑屏障,并在大脑中转化为多巴胺。Levodopa具有抗痛觉过敏作用。Levodopa还具有帕金森氏病的研究潜力。 | |||
T37847 |
Zonisamide-13C2,15N
Zonisamide-13C2,15N |
||
Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide is an antiepileptic agent.1 It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml.2 In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium... |